X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1811) 1811
humans (1803) 1803
male (1013) 1013
female (998) 998
middle aged (847) 847
aged (832) 832
oncology (762) 762
adult (622) 622
cancer (567) 567
chemotherapy (566) 566
biliary tract neoplasms - drug therapy (559) 559
treatment outcome (454) 454
cholangiocarcinoma (434) 434
gastroenterology & hepatology (425) 425
gemcitabine (424) 424
deoxycytidine - analogs & derivatives (392) 392
surgery (361) 361
antineoplastic combined chemotherapy protocols - therapeutic use (354) 354
aged, 80 and over (327) 327
medicine & public health (271) 271
biliary tract cancer (270) 270
biliary tract neoplasms - pathology (268) 268
prognosis (260) 260
cisplatin (252) 252
deoxycytidine - administration & dosage (252) 252
carcinoma (244) 244
retrospective studies (242) 242
biliary tract (223) 223
liver (219) 219
animals (215) 215
cholangiocarcinoma - drug therapy (214) 214
survival (207) 207
bile duct neoplasms - drug therapy (206) 206
disease-free survival (192) 192
tumors (190) 190
biliary-tract cancer (186) 186
care and treatment (186) 186
abridged index medicus (179) 179
phase-ii trial (179) 179
research (179) 179
intrahepatic cholangiocarcinoma (178) 178
antineoplastic agents - therapeutic use (175) 175
biliary tract neoplasms - mortality (175) 175
gallbladder (171) 171
neoplasm staging (171) 171
cholangiocarcinoma - pathology (170) 170
gallbladder cancer (170) 170
bile duct neoplasms - pathology (168) 168
risk factors (166) 166
survival rate (166) 166
antineoplastic combined chemotherapy protocols - adverse effects (163) 163
health aspects (160) 160
5-fluorouracil (157) 157
pharmacology & pharmacy (153) 153
deoxycytidine - therapeutic use (151) 151
analysis (150) 150
gallbladder neoplasms - drug therapy (145) 145
cell line, tumor (143) 143
cisplatin - administration & dosage (143) 143
survival analysis (143) 143
fluorouracil - administration & dosage (137) 137
gastroenterology (136) 136
patients (134) 134
phase-ii (132) 132
therapy (132) 132
gallbladder carcinoma (131) 131
adenocarcinoma - drug therapy (128) 128
diagnosis (128) 128
hepatocellular-carcinoma (128) 128
pancreatic cancer (127) 127
pancreatic neoplasms - drug therapy (126) 126
deoxycytidine - adverse effects (121) 121
bile ducts, intrahepatic (119) 119
combination (119) 119
oxaliplatin (119) 119
kaplan-meier estimate (116) 116
liver neoplasms - drug therapy (115) 115
metastasis (113) 113
adenocarcinoma (110) 110
hilar cholangiocarcinoma (110) 110
antimetabolites, antineoplastic - therapeutic use (109) 109
mice (108) 108
cancer therapies (107) 107
clinical trials (107) 107
multicenter (105) 105
gallbladder neoplasms - pathology (104) 104
pathology (103) 103
trial (103) 103
capecitabine (102) 102
follow-up studies (102) 102
liver diseases (102) 102
primary sclerosing cholangitis (102) 102
antineoplastic combined chemotherapy protocols - administration & dosage (100) 100
drug administration schedule (99) 99
disease progression (98) 98
management (97) 97
chemotherapy, adjuvant (96) 96
expression (96) 96
liver cancer (95) 95
combined modality therapy (94) 94
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (83) 83
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1969) 1969
Japanese (56) 56
German (14) 14
French (12) 12
Italian (8) 8
Spanish (4) 4
Czech (2) 2
Korean (2) 2
Russian (2) 2
Chinese (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 181 - 188
Summary Background Combination chemotherapy with gemcitabine and a platinum-based agent is regarded as a standard treatment for patients with advanced... 
Hematology, Oncology and Palliative Medicine | PLUS GEMCITABINE | CHOLANGIOCARCINOMA | CISPLATIN | ONCOLOGY | ADENOCARCINOMA | PANCREATIC-CANCER | CLINICAL-TRIALS | II TRIAL | COMBINATION | CHEMOTHERAPY | GALL-BLADDER CANCER | Erlotinib Hydrochloride | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Gallbladder Neoplasms - epidemiology | Cholangiocarcinoma - epidemiology | Deoxycytidine - administration & dosage | Biliary Tract Neoplasms - epidemiology | Disease Progression | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Gallbladder Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Medical colleges | Chemotherapy | Erlotinib | Gemcitabine | Pancreatic cancer | Oncology, Experimental | Clinical trials | Research | Drug therapy, Combination | Cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 574 - 581
The combination of gemcitabine and oxaliplatin with panitumumab versus gemcitabine and oxaliplatin alone has been evaluated in a phase 2, randomized trial as a... 
KRAS | panitumumab | biliary cancer | chemotherapy | cholangiocarcinoma | gemcitabine and oxaliplatin (GEMOX) | GROWTH-FACTOR-RECEPTOR | GALLBLADDER CANCER | OPEN-LABEL | II TRIAL | CAPECITABINE | ADVANCED CHOLANGIOCARCINOMA | CETUXIMAB | THERAPY | ONCOLOGY | Adenocarcinoma - pathology | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Adult | Female | Adenocarcinoma - genetics | Bile Duct Neoplasms - genetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Ducts, Intrahepatic - pathology | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Treatment Outcome | Adenocarcinoma - drug therapy | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Bile Ducts, Extrahepatic - pathology | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Clinical trials | Usage | Dosage and administration | Gemcitabine | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2010, Volume 102, Issue 1, pp. 68 - 72
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 18, pp. 3125 - 3135
Abstract Background Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC)... 
Hematology, Oncology and Palliative Medicine | Advanced biliary tract cancer | BTC | PDGFRβ | Hif1α | VEGFR-3 | c-kit | Sorafenib | VEGFR-2 | Hand-foot syndrome | ADVANCED HEPATOCELLULAR-CARCINOMA | CHOLANGIOCARCINOMA | COMBINATION THERAPY | GALLBLADDER CARCINOMA | OPEN-LABEL | OXALIPLATIN | Hif1 alpha | TRIAL | SKIN TOXICITY | ONCOLOGY | PDGFR beta | ADVANCED GASTRIC-CANCER | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Prospective Studies | Humans | Middle Aged | Male | Hand-Foot Syndrome - etiology | Phenylurea Compounds - adverse effects | Biliary Tract Neoplasms - metabolism | Gallbladder Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Bile Ducts, Intrahepatic | Deoxycytidine - adverse effects | Female | Biliary Tract Neoplasms - drug therapy | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Duct Neoplasms - metabolism | Double-Blind Method | Drug Administration Schedule | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Niacinamide - adverse effects | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Chemokine CXCL12 - metabolism | Gallbladder Neoplasms - drug therapy | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Vascular Endothelial Growth Factors - metabolism | Aged | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Research | Gemcitabine | Oncology, Experimental | Cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 14, pp. 1273 - 1281
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 03/2016, Volume 108, Issue 3, p. 1
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 4, pp. 1358 - 1368.e4
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 12, pp. 1142 - 1148
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 967 - 978
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 17, pp. 2357 - 2363
Journal Article